UBS Group »

Marinus Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $903k 83k 10.87
2023-09-30 $452k 56k 8.05
2023-06-30 $391k 36k 10.86
2023-03-31 $585k 85k 6.90
2022-12-31 $302k 76k 3.98
2022-09-30 $641k 96k 6.66
2022-06-30 $465k 96k 4.84
2022-03-31 $0 34k 0.00
2021-12-31 $596k 50k 11.88
2021-09-30 $366k 32k 11.40
2021-06-30 $549k 31k 17.92
2021-03-31 $325k 21k 15.49
2020-12-31 $255k 21k 12.37
2020-09-30 $182k 14k 12.87